Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
- Chimiothérapie
Extract
An open-label, randomized, controlled phase-II trial evaluating the efficacy and safety of endoTAG-1 in triple receptor negative breast cancer patients.
Scientific Abstract
en cours d'intégration;